Tax News Update    Email this document    Print this document  

November 17, 2021
2021-2105

IRS publishes rules requiring health plans and health insurance issuers to submit information on Rx drug and health care spending

The IRS has issued interim final regulations (TD 9958) that require group health plans and health insurance issuers to submit certain information on prescription drug and health care spending to the Departments of Treasury, Health and Human Services, and Labor. The regulations will become generally applicable on December 27, 2021, although enforcement will be limited during the first year of applicability. A notice of proposed rulemaking (REG-117575-21) invites comments on the regulations to be submitted by January 24, 2022.

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement